CELLB9® is an oral dilute solution infused with select peptides sourced exclusively from Caribbean Blue Scorpion venom. The active potentiated ingredients, in CELLB9® appear to support health at a deep cellular level, having been used in over 40 countries for well over a decade. CELLB9® is owned and produced by PreveCeutical Medical Inc, a health sciences company that develops innovative options for preventive and curative therapies utilising organic and nature identical products.

PreveCeutical® has a number of exciting research and development programs one of which is called "Nature Identical™". A leg of this program, inspired by CELLB9®, is the Venom Re-engineering Project which consists of three distinct phases. Currently underway, phase one ("1DE" of preclinical) results have already been detailed in a news release on August 11, 2017. Please check out www.preveceutical.com for more details.